AAO

Expert on IFIS offers practical pearls for success

Cataract surgeons must consider medication history as part of preoperative evaluation.

Tarsus execs discuss origins, treating Demodex blepharitis

Tarsus Pharmaceuticals's CEO Bobby Azamian, MD, PhD, and Chairman Michael Ackermann, PhD, speak on the development of their company and the latest updates on their lead candidate product to treat Demodex blepharitis.

Visus CEO updates on lead product candidate, 2021 pipeline

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.

Evaluating long-term safety of micro-bypass implant with phaco in PXG

December 12, 2020

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.